Attached files

file filename
EX-32.1 - EX-32.1 - Benitec Biopharma Inc.d943701dex321.htm
EX-31.2 - EX-31.2 - Benitec Biopharma Inc.d943701dex312.htm
EX-31.1 - EX-31.1 - Benitec Biopharma Inc.d943701dex311.htm
10-Q - 10-Q - Benitec Biopharma Inc.d943701d10q.htm


Statement Pursuant to Section 906 the Sarbanes-Oxley Act of 2002


Principal Financial Officer

Regarding Facts and Circumstances Relating to Exchange Act Filings

Dated: November 13, 2020

I, Megan Boston, Executive Director (principal accounting officer) of Benitec Biopharma Inc., hereby certify, to my knowledge, that:

1. the accompanying Quarterly Report on Form 10-Q of Benitec Biopharma Inc. for the three month period ended September 30, 2020 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities and Exchange Act of 1934, as amended; and

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Benitec Biopharma Inc.


/s/ Megan Boston

Megan Boston
Executive Director (principal accounting officer)